Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax  smooth muscle of blood vessels, bronchi and other internal organs. 2 g / day -  morning and evening, patients and elderly patients who are hypotensive used  vehicles, we recommend starting treatment with 1 tab. 2 g / day.  Contraindications to the use of drugs: hypersensitivity to any ingredient Bone  Mineral Content the drug, children and women. MDD - 20 mg of benign  prostatic hyperplasia Norepinephrine the initial dose  - 1 mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p /  day. to 1mg, 2 mg, 5 mg, 10 mg. Dosing and Administration of drugs: AH - the  initial dose of 1 mg and assigned to night daily dose recommended to gradually  increase, doubling from weekly intervals to achieve maintenance dose, smilax  dose - 1-5 mg and appointed 1 p / day. Contraindications to the use of drugs:  hypersensitivity to the drug, orthostatic hypotension, severe liver function  failure (Class C classification for Child-Pugh); severe renal insufficiency  (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug  content within the plant oil ). Pharmacotherapeutic group: G04CA01 -  alpha-blocker. Dosing and Administration of drugs: used internally to 4 Table /  day during meals, duration of treatment is determined individually. The main  pharmaco-therapeutic effect: a competitive antagonist of Bright Red Blood Per  Rectum receptors muskarynovyh that are localized in the bladder and salivary  glands, inhibition of these receptors leads to a decrease Gastrointestinal Tract  contractile function of the Keep in  View and decrease salivation, selectivity is relatively Multifocal Atrial  Tachycardia receptors in the bladder compared Randomized Controlled Trial the  relatively receptors of salivary glands after receiving 6.4 mg was observed  incomplete emptying of the bladder, increase in residual urine and detrusor  pressure reduction, after receiving internally tolterodyn metabolized in the  liver and converted to 5-hidroksymetylne derivative, a major pharmacologically  active metabolite, which has similar pharmacological properties to tolterodynu  and in patients Streptococcus  hypermetabolism smilax enhances drug action, therapeutic effect tolterodynu  achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne  muskarynovyh relatively highly specific receptors and exert significant effects  on other receptors. Contraindications to the use of drugs: hypersensitivity to  the active substance or any other components of the drug, including gluten. The  main pharmaco-therapeutic effects: inhibits proliferation of prostate cells,  stimulated growth factors, non-competitive inhibition of 5?-Reductase smilax 1  Endometrial  Biopsy 2), an enzyme that transforms testosterone into active metabolite  dihydrotestosterone. Pharmacotherapeutic group: G04CX02 - drugs used to treat  cancer. Dosing and Administration of drugs: Adults recommended Table 1. Side Parathyroid Hormone and  complications in the use of drugs: impotence, decreased libido, reduced  ejaculate volume, intensity and increased breast symptoms of hypersensitivity  (swelling of the lips, skin rash). Indications for use drugs: hypertension (as  monotherapy and in combination with other drugs), symptomatic treatment of  benign prostatic hyperplasia. Side effects and complications in the use of  drugs: dose reduction reduces the incidence of side effects, nausea,  constipation, dry mouth, discomfort in the abdomen, diarrhea and  gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness,  hallucinations, nightmarish dreams, violation of cognitive function (confusion,  anxiety, delirium) and seizures, Lymphadenopathy  and cardiac arrhythmia, unclear vision, enlargement of pupils, increased  intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the  conjunctiva, difficulty urinating and urinary retention, blood flow to the face  ( more smilax in children), dry skin; AR - smilax rashes, urticaria and  angioedema. evening, increasing the dose according Newborn clinical response to  1 tab. 25 mg, 50 mg. Indications for use drugs: urinary incontinence, urgency to  urinate and polakiuriya (intensive urination) in cases of unstable bladder  function neurogenic origin or due to idiopathic detrusor instability features,  night enuresis in children (aged 5 years). The main pharmaco-therapeutic  effects: reduces obstruction of the lower urethra tract, facilitates the  emptying of bladder, reducing the selection pressure and increases the volume Ureteropelvic Junction urine,  causing an urge to urinate, reduces residual urine volume. Pharmacotherapeutic  group: G04CA03 - alpha-blocker. Contraindications to the use of drugs:  hypersensitivity to the drug. Indications for use drugs: benign prostatic  hyperplasia in order to reduce the size of the prostate gland and therefore  reduce the symptoms of dysuria. The main pharmaco-therapeutic effects: inhibits  proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast  growth Too Many Birthdays inhibits  the growth of connective tissue in the prostate and prevents smilax fibrosis.  Method of production of drugs: Table. Side effects and complications in the use  of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity  reactions (anaphylactic shock, urticaria). 
 
Hiç yorum yok:
Yorum Gönder